Sex Differences in Pharmacologic Optimal Medical Therapy for Ischemic Heart Disease

Key Result

Sex disparities in pharmacologic treatment for ischemic heart disease remain poorly characterized in recent years despite guideline recommendations for optimal medical therapy.

Key Points

• The aim is to examine the differences in pharmacologic treatment for ischemic heart disease based on sex.
• Reviewed guidelines for optimal medical therapy for ischemic heart disease.
• Analyzed available data on pharmacologic treatments across genders.
• Identified disparities in treatment approaches based on sex.
• Highlighted significant gaps in treatment adherence for women compared to men.
• Noted that women are often underrepresented in clinical trials related to ischemic heart disease.